Gyeonggi-do / Tokyo / Daegu / Seoul / San Jose / St. Louis / /
Company
Komabiotech Inc / Nikon / Armour / Korean Cell Line Bank / Corning Inc / Creative Commons / BD Biosciences / CO2 / Detmer SA / Macmillan Publishers Limited / /
Country
Japan / United States / Korea / South Korea / /
Currency
pence / / /
Facility
Kwangwoon University / The Catholic University of Korea / /
IndustryTerm
precise micro-plasma jet device / media containing / cancer therapy / cancer therapies / cell culture media / stainless steel mesh electrode / culture media / cancer treatment / final products / media measurement / inside media / final product / dye solution / physiological solutions / stainless steel mesh / tubular networks / reagent containing horseradish peroxidase solution / plasma device / galactose media / therapeutic applications / lung cancer therapy / /
MedicalCondition
human large-cell lung carcinoma / dysfunction / carcinoma / J Cancer / HepG2 cancer / lethal cancer / maximal cancer / human liver cancer / plasma cancer / non-small cell lung cancer / lung cancers / mitochondria dysfunction / mitochondrial dysfunction / human squamous-cell lung carcinoma / Cancer / Disease / Stephanou Human lung cancer / human lung cancer / Carcinogenesis / mitochondrial enzymatic dysfunction / cancer therapy / human embryonic pulmonary epithelial cells / lung cancer / selective cancer / brain cancer / HCC1588 lung cancer / plasma-treated H460 cancer / higher cell death Human lung cancer / H460 cancer / /
MedicalTreatment
chemotherapy / surgery / cancer therapy / lung cancer therapy / cancer therapies / /
Organization
Catholic University of Korea / Seoul / Korean Government / Department of Plasma Bioscience and Display / Kwangwoon University / Seoul / 2Plasma Bioscience Research Center / National Research Foundation / /
Person
Ann Biomed Eng / Huang P. Preferential / Lin Y. Antitumor / Liang J. Caspase / /
Preferential killing of human lung cancer cell lines with mitochondrial dysfunction by nonthermal dielectric barrier discharge plasma